Journal for ImmunoTherapy of Cancer (Nov 2020)

837 Interleukin-10 drives the development of T regulatory type 1 (Tr1) cells and is a target for immunotherapy

  • Yanchun Ma,
  • Vera Bauer,
  • Tanja Riedel,
  • Thomas Hofer,
  • Martin Roecken,
  • Ralph Mocikat

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0837
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.